PYFA

Pyridam Farma Tbk

PYFA.JK pyfa.co.id
250.00
-4.00 (-1.57%)
IDR · JK
52-week range
158.00
665.00
Trading at 18% of the 52-week range
Market Cap
2.88T
P/E Ratio
0.00
Forward P/E
0.00
Book Value
60.89
Div. Yield
N/A
% Institutions
0.034%
% Insiders
65.41%

1 Year

-50.7%

3 Year

-66.6%

10 Year

+74.1%
Description

PT Pyridam Farma Tbk engages in the pharmaceutical business in Australia, Indonesia, Philippines, Singapore, and India. The company operates through two segments, Pharmaceutical Products, Esthetic and Toll Manufacturing Services; and Medical Equipment segments. It supplies medical instruments and equipment, including clinical waste, collection swab, collection tube, innerbox DCA, KF94 mask, parafilm, PCR - extraction kit and extractor machine, speciment bag, sterile container, PCR machine- Gentier 48, and tube stopper. The company also provides skin care and beauty products; medical support products; and other consumer health products in the form of syrups, tablets, and capsules; sterile and injection; and sanitizers and antiseptics. In addition, it offers antiseptic solutions, betadine antiseptic skin cleansers, Betadine Vaginal Douche, Cold defense nasal and throat sprays, feminine hygiene, Guardix SG, Mouthwash and Gargle, Salep antiseptic products. PT Pyridam Farma Tbk was founded in 1976 and is headquartered in Jakarta Selatan, Indonesia. PT Pyridam Farma Tbk operates as a subsidiary of Rejuve Global Investment Pte. Ltd.

Company Information

Company Name
Pyridam Farma Tbk
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
JK
ISIN: ID1000075609
Currency: IDR
Full Time Employees: 2,463
Phone: 62 21 5099 1067
Website: pyfa.co.id
Fiscal Year End: December
IPO Date: Oct 16, 2001
Description:

PT Pyridam Farma Tbk engages in the pharmaceutical business in Australia, Indonesia, Philippines, Singapore, and India. The company operates through two segments, Pharmaceutical Products, Esthetic and Toll Manufacturing Services; and Medical Equipment segments. It supplies medical instruments and equipment, including clinical waste, collection swab, collection tube, innerbox DCA, KF94 mask, parafilm, PCR - extraction kit and extractor machine, speciment bag, sterile container, PCR machine- Gentier 48, and tube stopper. The company also provides skin care and beauty products; medical support products; and other consumer health products in the form of syrups, tablets, and capsules; sterile and injection; and sanitizers and antiseptics. In addition, it offers antiseptic solutions, betadine antiseptic skin cleansers, Betadine Vaginal Douche, Cold defense nasal and throat sprays, feminine hygiene, Guardix SG, Mouthwash and Gargle, Salep antiseptic products. PT Pyridam Farma Tbk was founded in 1976 and is headquartered in Jakarta Selatan, Indonesia. PT Pyridam Farma Tbk operates as a subsidiary of Rejuve Global Investment Pte. Ltd.

Address:

Sinar Mas Land Plaza Sudirman, Jakarta Selatan, Indonesia, 12920

People

Directors & Officers

Name Title Year Born
Mr. Yan Gwan Lee President Director 1963
Mr. Yenfrino Gunadi CFO & Director 1987
Dr. Paulus Widjanarko Brotosaputro COO, Head of Pharmacovigilance & President Commissioner 1965
Ms. Sinta Lestari Ningsih VP of Finance, Accounting & Tax and Director NA
Ms. Nadia Miranty Verdiana Head of Legal 1991
Joshua Sandjaja HRD Manager NA
Andrey Septiana Head of OTC NA
Mr. Antes Eko Prasetio Chief Commercial Officer & Director NA
Mr. Panji Pamungkas Head of the Internal Audit Unit NA
Ms. Herdiasti Anggitya Dwisani Corporate Secretary NA

Financial Highlights

Market Cap: $2,876.61B
EBITDA: $82.89B
Book Value: $60.89
Earnings/Share: $-29.56
Profit Margin: -11.52%
Operating Margin: -0.17%
ROA (TTM): -0.88%
ROE (TTM): -39.27%
Revenue (TTM): $2,992.54B
Revenue/Share (TTM): $259.03
Earnings Growth (YOY): 5,982.50%
Revenue Growth (YOY): 21.60%

Valuation Metrics

Enterprise Value: $8,177.38B
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 11.24B
Shares Float: 3.36B
% Insiders: 65.41%
% Institutions: 0.034%

Stock Price History

1 Year Price History

3 Years Price History

10 Years Price History

Financial Charts

Revenue, Net Income & Operating Cash Flow (Yearly)

Revenue, Net Income & Operating Cash Flow (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$2,760.42B
Cost of Goods Sold
adjust
$-2,274.88B
Gross Profit
subtotal
$485.54B
SG&A
adjust
$-119.18B
R&D
adjust
$-21.54B
Other Operating Expense
adjust
$-508.92B
Operating Income
subtotal
$-164.10B
Other / Non-Operating Items
adjust
$-215.57B
Net Income
subtotal
$-379.67B

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about PYFA.JK!